Intuitive Surgical, Inc. $ISRG Shares Sold by Atria Investments Inc

Atria Investments Inc decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 29,499 shares of the medical equipment provider’s stock after selling 4,288 shares during the period. Atria Investments Inc’s holdings in Intuitive Surgical were worth $13,193,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Tobam raised its position in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Kilter Group LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $27,000. Princeton Global Asset Management LLC acquired a new position in Intuitive Surgical during the second quarter valued at approximately $30,000. Finally, Guerra Advisors Inc purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $496,455.52. The trade was a 83.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 56,189 shares of company stock valued at $30,785,441. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 3.5%

Shares of Intuitive Surgical stock opened at $478.60 on Friday. The business has a 50-day moving average price of $543.41 and a 200 day moving average price of $510.30. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08. The firm has a market cap of $169.97 billion, a P/E ratio of 60.66, a P/E/G ratio of 3.84 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the business earned $2.21 EPS. The business’s quarterly revenue was up 18.8% on a year-over-year basis. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have commented on ISRG. Rothschild & Co Redburn raised their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Citigroup reissued a “neutral” rating and set a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Raymond James Financial upped their target price on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $617.23.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Company fundamentals: Intuitive beat January quarter revenue and EPS estimates and management highlighted continued procedure growth and da Vinci 5 adoption — a reminder the growth engine remains intact. Read More.
• Positive Sentiment: Analyst support: The broker community still leans positive overall (many Buy/Overweight ratings and several price-target raises), which provides a floor if execution continues.
• Neutral Sentiment: Technicals and flow: Traders are focused on the recent pullback vs. 50‑ and 200‑day moving averages; technical positioning can amplify near‑term moves even if fundamentals are stable. Read More.
• Neutral Sentiment: Short‑interest reports in recent feeds show anomalous zero/NaN values and should be treated with caution — they don’t appear to explain today’s move.
• Negative Sentiment: Insider selling: Multiple insider sales disclosed in early February (EVP Myriam Curet and VP Fredrik Widman) are prompting short‑term negative sentiment and may be interpreted as profit‑taking. Read More. Read More.
• Negative Sentiment: Valuation and recent underperformance: Coverage questioning whether ISRG is “priced for perfection” after a pullback and a ~13% three‑month decline is keeping some investors cautious despite the beat. Read More. Read More.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.